NeuroMetrix Announces Frank McGillin, SVP and General Manager, Consumer to participate in a Digital Health Summer Summit
Panel at BIO 2016
NeuroMetrix, Inc. (Nasdaq: NURO) announced that Frank McGillin, Senior Vice President and General Manager, Consumer will
participate in a panel discussion entitled "The Rise of Enterprise & Condition-Specific Wearables” during the Fifth Annual
Digital Health Summer Summit. Digital Health is co-located with the 2016 Bio International Convention at the Moscone Center in San
Francisco and the panel discussion will be held on Tuesday, June 7 at 11:15am (Pacific).
Mr. McGillin will join other industry leaders including moderator Chris Bergstrom, Associate Director - Digital Health, BCG;
Rich Buchler Co-Founder and CEO, VIZR Tech; Ben Hwang, CEO, Profusa; and Ashwin Pushpala, CEO, Sano Intelligence Inc.
"The theme of the Digital Health Summit event is Igniting the Tipping Point," said Mr. McGillin, "The fact that digital
health is also a track at BIO 2016 is a good indication that the time is right for innovative technology that addresses the burden
of chronic disease. Products like Quell® are an example of what is possible in a sophisticated connected consumer health
device."
The Fifth Annual Digital Health Summer Summit at BIO 2016 takes a deep dive into the elements of a successful digital health
venture and showcases the latest digital health innovations from the industry’s leaders and organizations who will explore the
issues and opportunities facing the industry.
About Quell
Quell utilizes NeuroMetrix's patented neurostimulation technology to provide widespread relief from chronic pain. The advanced
wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the
FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their
chronic pain. Quell includes a smartphone app that tracks and personalizes their pain therapy. It is available for purchase at
QuellRelief.com, selected retailers and healthcare professionals.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help
patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham,
Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more
information, please visit www.NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160518005185/en/